Literature DB >> 9811764

Equine infectious anemia virus Gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly.

B A Puffer1, S C Watkins, R C Montelaro.   

Abstract

We have identified an interaction between the equine infectious anemia virus (EIAV) late assembly domain and the cellular AP-2 clathrin-associated adapter protein complex. A YXXL motif within the EIAV Gag late assembly domain was previously characterized as a sequence critical for release of assembling virions. We now show that this YXXL sequence interacts in vitro with the AP-50 subunit of the AP-2 complex, while the functionally interchangeable late assembly domains carried by the Rous sarcoma virus p2b protein and human immunodeficiency virus type 1 p6 protein, which utilize PPPY and PTAPP L domains, respectively, do not bind AP-50 in vitro. In addition, EIAV late domain mutants containing mutations that have previously been shown to abrogate budding also exhibit marked decreases in AP-50 binding efficiencies. A role for AP-2 complex in viral assembly is supported by immunofluorescence analysis of EIAV-infected equine dermal cells demonstrating specific colocalization of the alpha adaptin subunit of AP-2 with the EIAV p9 protein at sites of virus budding on the plasma membrane. These data provide strong evidence that EIAV utilizes the cellular AP-2 complex to accomplish virion assembly and release.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9811764      PMCID: PMC110572     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  24 in total

1.  Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide.

Authors:  V M Vogt; R Eisenman; H Diggelmann
Journal:  J Mol Biol       Date:  1975-08-15       Impact factor: 5.469

2.  A proline-rich motif (PPPY) in the Gag polyprotein of Mason-Pfizer monkey virus plays a maturation-independent role in virion release.

Authors:  J Yasuda; E Hunter
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

3.  WW domains and retrovirus budding.

Authors:  L Garnier; J W Wills; M F Verderame; M Sudol
Journal:  Nature       Date:  1996-06-27       Impact factor: 49.962

4.  Isolation and comparative biochemical properties of the major internal polypeptides of equine infectious anemia virus.

Authors:  R C Montelaro; N Lohrey; B Parekh; E W Blakeney; C J Issel
Journal:  J Virol       Date:  1982-06       Impact factor: 5.103

5.  Fine mapping and characterization of the Rous sarcoma virus Pr76gag late assembly domain.

Authors:  Y Xiang; C E Cameron; J W Wills; J Leis
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

6.  Interaction of endocytic signals from the HIV-1 envelope glycoprotein complex with members of the adaptor medium chain family.

Authors:  H Ohno; R C Aguilar; M C Fournier; S Hennecke; P Cosson; J S Bonifacino
Journal:  Virology       Date:  1997-11-24       Impact factor: 3.616

7.  Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein.

Authors:  B A Puffer; L J Parent; J W Wills; R C Montelaro
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

8.  A membrane-proximal tyrosine-based signal mediates internalization of the HIV-1 envelope glycoprotein via interaction with the AP-2 clathrin adaptor.

Authors:  M Boge; S Wyss; J S Bonifacino; M Thali
Journal:  J Biol Chem       Date:  1998-06-19       Impact factor: 5.157

9.  Interaction of tyrosine-based sorting signals with clathrin-associated proteins.

Authors:  H Ohno; J Stewart; M C Fournier; H Bosshart; I Rhee; S Miyatake; T Saito; A Gallusser; T Kirchhausen; J S Bonifacino
Journal:  Science       Date:  1995-09-29       Impact factor: 47.728

10.  Expression and localization of alpha-adaptin isoforms.

Authors:  C L Ball; S P Hunt; M S Robinson
Journal:  J Cell Sci       Date:  1995-08       Impact factor: 5.285

View more
  62 in total

Review 1.  Ubiquitin in retrovirus assembly: actor or bystander?

Authors:  V M Vogt
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

2.  Ubiquitin is part of the retrovirus budding machinery.

Authors:  A Patnaik; V Chau; J W Wills
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

Review 3.  Viral late domains.

Authors:  Eric O Freed
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

4.  Role of ESCRT-I in retroviral budding.

Authors:  Juan Martin-Serrano; Trinity Zang; Paul D Bieniasz
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

5.  A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding.

Authors:  R N Harty; M E Brown; G Wang; J Huibregtse; F P Hayes
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-05       Impact factor: 11.205

6.  Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4.

Authors:  Jillian M Licata; Martha Simpson-Holley; Nathan T Wright; Ziying Han; Jason Paragas; Ronald N Harty
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

7.  The PPPY motif of human T-cell leukemia virus type 1 Gag protein is required early in the budding process.

Authors:  Isabelle Le Blanc; Marie-Christine Prévost; Marie-Christine Dokhélar; Arielle R Rosenberg
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

8.  Identification of domains in gag important for prototypic foamy virus egress.

Authors:  Gillian S Patton; Stephen A Morris; Wayne Chung; Paul D Bieniasz; Myra O McClure
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

9.  Evolution of feline immunodeficiency virus Gag proteins.

Authors:  Evan Burkala; Mary Poss
Journal:  Virus Genes       Date:  2007-01-30       Impact factor: 2.332

10.  Divergent retroviral late-budding domains recruit vacuolar protein sorting factors by using alternative adaptor proteins.

Authors:  Juan Martin-Serrano; Anton Yarovoy; David Perez-Caballero; Paul D Bieniasz; Anton Yaravoy
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-30       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.